Fundraising FoxSNGLR Capital AG
Venture capitalSeed
Find your way into SNGLR Capital AG
Sign up to find every way you can get introduced to SNGLR Capital AG
- Your email: who you already know at SNGLR Capital AG, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the SNGLR Capital AG team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
SNGLR invests mainly in European early-stage technology startups with exponential growth potential across two thematic seed funds: Fund I focused on Longevity & Vitality, and Fund II on Smart Mobility & Smart Cities. It targets companies whose solutions are enabled by key technologies including AI, blockchain, data (IoT, DePIN, API), AIoT and robotics. Beyond capital, the firm supports founders as one team, drawing on experience as founders, early-stage investors, board members, advisors, mentors and coaches. It offers a special engagement model with selected corporate venture units and consulting firms for market access, plus deep technology insight through its XLabs experts.
Source: firm website, verified Aug 3, 2026.
Frequently asked questions
- What stage does SNGLR Capital AG invest at?
- SNGLR Capital AG invests at the Seed stage.
- What sectors does SNGLR Capital AG focus on?
- SNGLR Capital AG focuses on AI & Machine Learning, Crypto & Web3, Deep Tech, IoT, Longevity, Mobility & Transportation, Robotics, Wellness & Fitness.
Similar investors
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.
TRIVE is a Singapore-based venture capital firm backing early-stage founders across Southeast Asia in technology, Web3/blockchain, and AI. It operates three strategies — TRIVE Ventures, TRIVE Digital, and a venture-build arm TRIVE Growth.
ECP Growth (formerly Emil Capital Partners) is a growth-stage investment firm backing B2B and B2C companies across the consumer value chain, from better-for-you brands to commerce technology.
Embryo Ventures is an early-stage venture firm backing founders building technologies across human health and human experience, from clinical and consumer health to essential life infrastructure.